MRK. Merck Researchers Present BMD Data from a Phase II Study of Odanacatib, Merck’s Investigational Cat-K Inhibitor for Post-Menopausal Osteoporosis
Odanacatib Significantly Increased BMD Following Prior Alendronate Treatment
http://finance.yahoo.com/news/merck-researchers-present-bmd-data-161500788.html
Odanacatib Significantly Increased BMD Following Prior Alendronate Treatment
http://finance.yahoo.com/news/merck-researchers-present-bmd-data-161500788.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
